SCARLETRED Holding
AI-powered skin imaging and analysis software for biopharma & research.
| EUR | 2017 | 2018 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | (43 %) |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Scarletred is a digital health company focused on revolutionizing dermatology through the standardization and objectivity of skin imaging and assessment. The company operates in the digital health and telemedicine markets, providing innovative software products and services. Scarletred's primary clients include biopharma and cosmetics companies, hospitals, insurance firms, contract research organizations (CROs), and medical experts. The company offers its technology through a flexible Software as a Service (SaaS) model, enabling remote monitoring and analysis of over 3,000 skin diseases, including acne, atopic dermatitis, chronic wounds, drug allergies, and more. Scarletred's patented technology platform ensures data safety and superior data quality, leading to higher patient compliance and better clinical outcomes.
Keywords: digital health, dermatology, skin imaging, telemedicine, SaaS, biopharma, cosmetics, hospitals, insurance, CROs.